Alberta Investment Management Corp (AIMCo)’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-40,000
Closed -$2.16M 616
2025
Q4
$2.16M Buy
+40,000
New +$1.92M 0.01% 471
2025
Q2
Sell
-178,284
Closed -$10.9M 621
2025
Q1
$10.9M Buy
+178,284
New +$10.4M 0.07% 194
2024
Q3
Sell
-25,100
Closed -$1.04M 773
2024
Q2
$1.04M Sell
25,100
-22,800
-48% -$1.02M 0.01% 516
2024
Q1
$2.6M Sell
47,900
-18,902
-28% -$963K 0.03% 358
2023
Q4
$3.43M Buy
66,802
+18,902
+39% +$992K 0.03% 294
2023
Q3
$2.78M Hold
47,900
0.03% 354
2023
Q2
$3.06M Hold
47,900
0.03% 429
2023
Q1
$3.32M Sell
47,900
-104,067
-68% -$7.34M 0.03% 418
2022
Q4
$10.9M Sell
151,967
-1,200
-0.8% -$90.5K 0.1% 226
2022
Q3
$10.9M Buy
153,167
+16,500
+12% +$1.2M 0.08% 257
2022
Q2
$10.5M Buy
136,667
+100,467
+278% +$7.65M 0.08% 272
2022
Q1
$2.64M Sell
36,200
-121,763
-77% -$8.18M 0.02% 710
2021
Q4
$9.85M Buy
157,963
+31,978
+25% +$1.88M 0.06% 326
2021
Q3
$7.46M Sell
125,985
-31,597
-20% -$2.08M 0.06% 331
2021
Q2
$10.5M Sell
157,582
-23,003
-13% -$1.5M 0.09% 251
2021
Q1
$11.4M Buy
180,585
+2,285
+1% +$142K 0.1% 218
2020
Q4
$11.1M Sell
178,300
-10,300
-5% -$633K 0.1% 239
2020
Q3
$11.4M Sell
188,600
-82,500
-30% -$4.97M 0.12% 198
2020
Q2
$15.9M Buy
271,100
+62,600
+30% +$3.74M 0.19% 116
2020
Q1
$11.6M Sell
208,500
-653,550
-76% -$39.9M 0.21% 121
2019
Q4
$55.3M Sell
862,050
-379,150
-31% -$21.7M 0.47% 47
2019
Q3
$62.9M Sell
1,241,200
-61,000
-5% -$2.87M 0.59% 35
2019
Q2
$59.1M Buy
1,302,200
+549,000
+73% +$25.6M 0.54% 36
2019
Q1
$35.9M Buy
753,200
+301,000
+67% +$15M 0.34% 74
2018
Q4
$23.5M Buy
452,200
+214,200
+90% +$11.5M 0.25% 104
2018
Q3
$14.8M Buy
238,000
+215,900
+977% +$12.8M 0.13% 178
2018
Q2
$1.22M Buy
+22,100
New +$1.19M 0.01% 546
2018
Q1
Sell
-10,600
Closed -$650K 772
2017
Q4
$650K Sell
10,600
-25,200
-70% -$1.58M 0.01% 609
2017
Q3
$2.28M Sell
35,800
-2,500
-7% -$146K 0.02% 441
2017
Q2
$2.13M Buy
+38,300
New +$2.08M 0.02% 425
2017
Q1
Sell
-19,600
Closed -$1.15M 810
2016
Q4
$1.15M Buy
+19,600
New +$1.07M 0.01% 527
2016
Q3
Sell
-28,400
Closed -$2.09M 726
2016
Q2
$2.09M Buy
+28,400
New +$2.01M 0.02% 418
2015
Q2
Sell
-97,500
Closed -$6.29M 497
2015
Q1
$6.29M Hold
97,500
0.07% 339
2014
Q4
$5.75M Hold
97,500
0.06% 336
2014
Q3
$4.99M Hold
97,500
0.05% 350
2014
Q2
$4.73M Sell
97,500
-100,400
-51% -$4.95M 0.05% 357
2014
Q1
$10.3M Hold
197,900
0.12% 252
2013
Q4
$10.5M Sell
197,900
-61,500
-24% -$3.13M 0.13% 250
2013
Q3
$12M Hold
259,400
0.16% 216
2013
Q2
$12.2M Buy
+259,400
New +$11.3M 0.3% 85

Other funds holding BMY

Alberta Investment Management Corp (AIMCo)'s BMY Position: Q1 2026 in Review

Alberta Investment Management Corp (AIMCo) sold out of Bristol-Myers Squibb (BMY) in Q1 2026, closing a stake of 40,000 shares — an estimated $2.16M sold.

Alberta Investment Management Corp (AIMCo) first reported a position in BMY in Q2 2013 and held it in 40 quarters. The position peaked at $62.9M in Q3 2019. 2,521 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Alberta Investment Management Corp (AIMCo) reported no remaining Bristol-Myers Squibb position as of Q1 2026 after selling out during the quarter.
  • Alberta Investment Management Corp (AIMCo) sold 40,000 Bristol-Myers Squibb shares in Q1 2026, an estimated $2.16M.
  • Alberta Investment Management Corp (AIMCo) first reported a position in Bristol-Myers Squibb in Q2 2013 and held it in 40 quarters.
  • Alberta Investment Management Corp (AIMCo)'s Bristol-Myers Squibb position peaked at $62.9M in Q3 2019.
  • 2,521 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Alberta Investment Management Corp (AIMCo)'s 13F filing for Q1 2026, filed 29 Apr 2026.